Agala, Ponciana A.

HRN: 23-84-21  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/13/2023
10/20/2023
IVT
4.5g
Q6
Cellulitis; Hepatic Enceph
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: